ARTICLE | Distillery Therapeutics
Therapeutics: Dedicator of cytokinesis 5 (DOCK5)
March 19, 2015 7:00 AM UTC
In vitro and mouse studies suggest a DOCK5 inhibitor could help treat osteoporosis. DOCK5 has been implicated in osteoclast activity and bone resorption. In vitro, C21, a small molecule inhibitor of b...